Staphylococcus aureus, continues to be the leading cause of implant-associated osteomyelitis, including fracture related infections (FRI) and peri-prosthetic joint infection (PJI). To date, no vaccine for this important pathogen exists. As the unique specificity of S. aureus as a human pathogen becomes better understood, it seems that reliance on murine models to produce pre-clinical data presents many shortcomings and may have contributed to previous failures in vaccine development.
Develop a humanized mouse model of osteomyelitis.
Immunodeficient non-obese diabetic (NOD)–scid IL2Rγnull (NSG) mice are engrafted with human hematopoietic stem cells (HSC), and subjected to S. aureus transtibial implant-associated osteomyelitis. Interestingly, we observed that humanized mice have: 1) increased weight loss, staphylococcal abscess colonies (SACs), and extensive osteolysis during MRSA infection, 2) increased S. aureus dissemination to distant organs, 3) more severe S. aureus bacteraemia resulting from osteomyelitis when human T-cell numbers are low. This study presents significant step towards an appropriate animal model for studying a human-specific pathogen such as S. aureus.
PresentationSumrall E, Wallimann A, Hildebrand M, Zeiter S, Richards RG, Schwarz E, Moriarty TF, Muthukrishnan G. A humanized mouse model to exhibit Staphyloccocus aureus osteomyelitis. 2020 OBIC virtual (poster).
Muthukrishnan G (PhD), University of Rochester, USA
Schwarz E (Prof), University of Rochester, USA
Daiss J (PhD), University of Rochester, USA